RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS

Introduction. The anthracycline antibiotics cause clinically significant manifestations of cardiotoxicity (СТ) – myocardial injuries, reducing both quality and life expectancy of the oncological patients.The purpose of the study was to evaluate the incidence and risk factors anthracycline-induced СТ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: N. T. Vatutin, E. V. Sklyannaya, M. A. El-Khatib, I. A. Sologub
Formato: Artigo
Idioma:Russo
Publicado em: ABV-press 2017-10-01
Colecção:Onkogematologiâ
Assuntos:
chemotherapy
cardiotoxicity
anthracycline-induced cardiomyopathy
risk factors
cardioprotection
Acesso em linha:https://oncohematology.abvpress.ru/ongm/article/view/255
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados